Overview

Juvenile Rheumatoid Arthritis

Status:
Completed

Trial end date:
2003-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the safety of anakinra in patients with Polyarticular-Course Juvenile Rheumatoid Arthritis, a form of rheumatoid arthritis affecting children.

Phase:

Phase 2

Details

Lead Sponsor:

Amgen

Treatments:

Interleukin 1 Receptor Antagonist Protein